Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients-Reference-Cited by-全球学者库

Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients

Published:2015-06-18 Issue:5 Volume:55 Page:1024-1033
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol. Carcinog.

Author:

Lv Zhen¹,Weng Xiaoyu²,Du Chengli¹,Zhang Cheng²,Xiao Heng¹,Cai Xianlei²,Ye Sunyi²,Cheng Jun¹²,Ding Chaofeng¹²,Xie Haiyang²,Zhou Lin²,Wu Jian¹,Zheng Shusen¹²

Affiliation:

1. Division of Hepatobiliary and Pancreatic Surgery; Department of Surgery; The First Affiliated Hospital; School of Medicine; Zhejiang University; Hangzhou China

2. Key Laboratory of Combined Multi-Organ Transplantation; Ministry of Public Health; Zhejiang University; Hangzhou China

Funder

National High Technology Research and Development Program 863 of China

Special Fund for Health Research in the Public Welfare

National S&T Major Project

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference28 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Liver transplantation for hepatocellular carcinoma: Past, present, and future;Asham;Clin Transpl,2012

3. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future);Ishizaki;J Gastroenterol,2008

4. Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy;Yu;Oncology-Basel,2011

5. Cellular and molecular mechanisms of hepatocellular carcinoma: An update;Aravalli;Arch Toxicol,2013

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations of histone modifications in cancer;Epigenetics in Human Disease;2024

2. NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe;eBioMedicine;2023-12

3. Recent advances in EZH2-based dual inhibitors in the treatment of cancers;European Journal of Medicinal Chemistry;2023-08

4. Recent advancement of HDAC inhibitors against breast cancer;Medical Oncology;2023-06-09

5. Design and synthesis of novel uracil-linked Schiff bases as dual histone deacetylase type II/topoisomerase type I inhibitors with apoptotic potential;Future Medicinal Chemistry;2023-06